Orville
Back to product list
Enterol 1

Enterol

Capsules 250 mg

Composition: One capsule contains: Active ingredient: lyophilised Saccharomyces boulardii yeast 250.0 mg. Excipients: lactose monohydrate, magnesium stearate. Capsule shell: gelatin, titanium dioxide.

Form: Capsules

Indications: Acute and chronic diarrhea of bacterial etiology in adults and children; acute diarrhea of viral etiology; intestinal dysbacteriosis; prevention and treatment of traveler's diarrhea; AIDS-associated diarrhea; prevention and treatment of colitis and diarrhea caused by antibiotics; irritable bowel syndrome; pseudomembranous colitis and diseases caused by Clostridium difficile; diarrhea caused by prolonged enteral nutrition.

Contraindications: Hypersensitivity (allergy) to any component of the drug; patients with a central venous catheter; galactosemia, lactase deficiency, glucose-galactose malabsorption syndrome; children under 6 years of age (due to the dosage form).

Dosage: Swallow the capsule whole with a small amount of warm liquid. Children aged 6–12: 1 capsule 1–2 times daily. Adults and children over 12: 1–2 capsules twice daily. Recommended treatment course: • Acute diarrhoea: 3–5 days. • Acute and chronic bacterial diarrhoea and irritable bowel syndrome: 10–14 days. • Prevention and treatment of antibiotic-associated diarrhoea and pseudomembranous colitis: 2 capsules twice daily together with antibiotics throughout the antibiotic course.

Warnings: Do not take simultaneously with antifungal medicines when administered orally or parenterally. Enterol 250 should not be mixed with very hot (above 50°C) or very cold food or liquid. Do not take with alcohol.

Age restrictions: Powder: in newborns, no more than 1 sachet per day under a doctor's supervision; capsules: contraindicated in children under 6 years of age.

Pregnancy: Enterol 250 should be used during pregnancy and breastfeeding only in cases where the expected benefit to the mother outweighs the potential risk to the fetus or child.

Country of origin: France

Manufacturer: Biocodex

Storage conditions: Store protected from light at a temperature not exceeding 25°C. Keep out of reach of children.

Clinical studies:

Therapeutic potential of modern probiotics

Literature Review, 2013

Authors: N.I. Ursova

Read

Use of Enterol to eliminate dysbacteriosis and diarrhea of various origins in children

Literature Review, 2019

Authors: Nuraliyeva Rano Matyakubovna – head of clinical pharmacology course

Read

Probiotics from the perspective of evidence-based medicine

Scientific Review, 2019

Authors: V.O. Kaibysheva, E.L. Nikonov

Read

Correction of microbiocenosis in patients with duodenal bulb ulcer associated with Helicobacter pylori infection

Acta medica Eurasica, 2017

Authors: V.V. Zakharova, L.M. Karzakova

Read

Optimized eradication protocols

Diseases of the Esophagus and Stomach, 2017

Authors: S.I. Pimanov, E.V. Makarenko

Read

Opportunities to increase the effectiveness of Helicobacter pylori eradication

Diseases of the upper digestive tract, 2015

Authors: A.N. Kazyulin

Read

Saccharomyces boulardii modulate intestinal microbiota composition in patients with non-alcoholic fatty liver disease, preventing disease progression

Experimental and Clinical Gastroenterology, 2018

Authors: P.V. Seliverstov, S.I. Sitkin, V.G. Radchenko, L.B. Lazebnik, E.B. Avalueva, T.Ya. Vakhitov, E.V. Demyanova, T.E. Skvortsova, E.M. Prikhodko, M.A. Suvorova

Read

Clinical effectiveness of drugs based on probiotic strains of Saccharomyces boulardii

Bowel Diseases, 2020

Authors: V.N. Drozdov, K.I. Arefyev, S.Yu. Serebrova, E.V. Shikh

Read

Antibiotic-associated diarrhea in children

Consilium Medicum. Pediatrics, 2014

Authors: E.A. Kornienko

Read

Syndromes of impaired intestinal microbiocenosis in children: causes, diagnosis, therapy

Consilium Medicum. Pediatrics, 2015

Authors: N.I. Ursova

Read

Systematic review and meta-analysis of Saccharomyces boulardii in adult patients

World Journal of Gastroenterology, 2010

Authors: Lynne V McFarland

Read

Where to buy: